The Diagnostic Value Of Using ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma

References

• Zhang AS, Ostrom QT, Kruchko C, Rogers L, Peereboom DM, Barnholtz-Sloan JS. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010. Neuro-Oncology. 2016;19(5 ):726–735 doi:10.1093/neuonc/now252
   Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2 ):97–109. doi:10.1007/s00401-007-0243-417618441
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6 ):803–820. doi:10.1007/s00401-016-1545-127157931
   PubMed Web of Science ®Google Scholar
• Radner H, Blumcke I, Reifenberger G, Wiestler OD. [The new WHO classification of tumors of the nervous system 2000. Pathology and genetics]. Pathologe. 2002;23(4 ):260–283. doi:10.1007/s00292-002-0530-812185780
   PubMed Web of Science ®Google Scholar
• Kallio M, Sankila R, Hakulinen T, Jaaskelainen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992;31(1 ):2–12. doi:10.1227/00006123-199207000-000021641106
   PubMed Web of Science ®Google Scholar
• Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry. 2008;79(5 ):574–580. doi:10.1136/jnnp.2007.12158217766430
   PubMed Web of Science ®Google Scholar
• Lee JW, Kang KW, Park SH, et al. 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging. 2009;36(10 ):1574–1582. doi:10.1007/s00259-009-1133-x19377904
   PubMed Web of Science ®Google Scholar
• Potter M, Newport E, Morten KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44(5 ):1499–1505. doi:10.1042/BST2016009427911732
   PubMed Web of Science ®Google Scholar
• Tamrazi B, Shiroishi MS, Liu CS. Advanced imaging of intracranial meningiomas. Neurosurg Clin N Am. 2016;27(2 ):137–143. doi:10.1016/j.nec.2015.11.00427012378
   PubMed Web of Science ®Google Scholar
• Macapinlac HA. Positron emission tomography of the brain. PET Clin. 2007;2(1 ):1–13. doi:10.1016/j.cpet.2007.09.00127157702
   PubMedGoogle Scholar
• Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O’Malley JP. 18F-FDG PET and PET/CT patient preparation: a review of the literature. J Nucl Med Technol. 2014;42(1 ):5–13. doi:10.2967/jnmt.113.13262124503347
   PubMedGoogle Scholar
• Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48(9 ):1468–1481. doi:10.2967/jnumed.106.03768917704239
   PubMed Web of Science ®Google Scholar
• Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49(3 ):480–508. doi:10.2967/jnumed.107.04778718287273
   PubMed Web of Science ®Google Scholar
• Patel CN, Goldstone AR, Chowdhury FU, Scarsbrook AF. FDG PET/CT in oncology: “raising the bar”. Clin Radiol. 2010;65(7 ):522–535. doi:10.1016/j.crad.2010.01.00320541652
   PubMed Web of Science ®Google Scholar
• Suchorska B, Tonn JC, Jansen NL. PET imaging for brain tumor diagnostics. Curr Opin Neurol. 2014;27(6 ):683–688. doi:10.1097/WCO.000000000000014325333605
   PubMed Web of Science ®Google Scholar
• Arita H, Kinoshita M, Okita Y, et al. Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography. J Neurooncol. 2012;107(2 ):379–386. doi:10.1007/s11060-011-0759-222089887
   PubMed Web of Science ®Google Scholar
• Cremerius U, Bares R, Weis J, et al. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET. J Nucl Med. 1997;38(1 ):26–30.8998144
   PubMed Web of Science ®Google Scholar
• Ghodsian M, Obrzut SL, Hyde CC, Watts WJ, Schiepers C. Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT. Clin Nucl Med. 2005;30(11 ):717–720. doi:10.1097/01.rlu.0000183612.63129.4416237292
   PubMed Web of Science ®Google Scholar
• Lau EW, Drummond KJ, Ware RE, et al. Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour. J Clin Neurosci. 2010;17(1 ):43–49. doi:10.1016/j.jocn.2009.05.00920004582
   PubMed Web of Science ®Google Scholar
• Okuchi S, Okada T, Yamamoto A, et al. Grading meningioma: a comparative study of thallium-SPECT and FDG-PET. Medicine. 2015;94(6 ):e549. doi:10.1097/MD.000000000000054925674763
   PubMed Web of Science ®Google Scholar
• Tateishi U, Tateishi K, Shizukuishi K, et al. 18F-Fluoride PET/CT allows detection of hyperostosis and osseous involvement in meningioma: initial experience. Clin Nucl Med. 2013;38(3 ):e125–e131. doi:10.1097/RLU.0b013e318279fd7923412601
   PubMed Web of Science ®Google Scholar
• Tsuyuguchi N. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas–comparison with gliomas. Osaka City Med J. 1997;43(2 ):209–223.9540343
   PubMedGoogle Scholar
• Xiangsong Z, Xingchong S, Chang Y, Xiaoyan W, Zhifeng C. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report. Clin Nucl Med. 2011;36(11 ):1003–1006. doi:10.1097/RLU.0b013e3182291c2a21975388
   PubMed Web of Science ®Google Scholar
• Cremerius U, Striepecke E, Henn W, et al. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis]. Nuklearmed Nucl Med. 1994;33(4 ):144–149.
   Google Scholar
• Iuchi T, Iwadate Y, Namba H, et al. Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res. 1999;21(7 ):640–644. doi:10.1080/01616412.1999.1174098910555183
   PubMed Web of Science ®Google Scholar
• Liu RS, Chang CP, Guo WY, et al. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med. 2010;51(6 ):883–891. doi:10.2967/jnumed.109.07056520484430
   PubMed Web of Science ®Google Scholar
• Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122(1 ):4–23. doi:10.3171/2014.7.JNS13164425343186
   PubMed Web of Science ®Google Scholar
• Sughrue ME, Sanai N, Shangari G, Parsa AT, Berger MS, McDermott MW. Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg. 2010;113(2 ):202–209. doi:10.3171/2010.1.JNS09111420225922
   PubMed Web of Science ®Google Scholar